发明公开
- 专利标题： MODULATION OF SMAD3 EXPRESSION
- 专利标题（中）： 调制表达SMAD3的
-
申请号： EP11748173.9申请日： 2011-02-25
-
公开(公告)号： EP2539356A1公开(公告)日： 2013-01-02
- 发明人: DEAN, Nicholas, M. , FOULKES, J., Gordon , FREIER, Susan, M. , BENNETT, C., Frank , GAARDE, William, A.
- 申请人： Isis Pharmaceuticals, Inc. , Excaliard Pharmaceuticals, Inc.
- 申请人地址： 2855 Gazelle Court Carlsbad, CA 92010 US
- 专利权人： Isis Pharmaceuticals, Inc.,Excaliard Pharmaceuticals, Inc.
- 当前专利权人： Isis Pharmaceuticals, Inc.,Excaliard Pharmaceuticals, Inc.
- 当前专利权人地址： 2855 Gazelle Court Carlsbad, CA 92010 US
- 代理机构： Carpmaels & Ransford
- 优先权： US308847P 20100226
- 国际公布： WO2011106689 20110901
- 主分类号： C07H21/00
- IPC分类号： C07H21/00 ; C12N15/11
摘要：
Provided are compounds capable of inhibiting SMAD3 and compositions containing same as well as methods using such compounds for treating fibrosis and scarring.
信息查询
